Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2002-10-15
2008-11-18
Huff, Sheela J (Department: 1643)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C424S185100, C424S277100, C514S012200
Reexamination Certificate
active
07452540
ABSTRACT:
This invention provides for methods of immunizing mammals against tumors expressing a carcinoembryonic antigen using a carcinoembryonic immunogen modified to lack cellular immunosuppressive activity or CD1d binding. The invention further provides for use of a carcinoembryonic immunogen having a region recognized by antibody B9 or L12 modified to inactivate cellular immunosuppressive activity. Methods are also provided for modifying the immunogen by deleting, altering, mutating or truncating the immunosuppressive region. The invention also provides for enhancing cellular immunogenicity of an orally delivered immunogen by co-administration of an agent capable of inhibiting the immunosuppressive activity of carcinoembryonic antigen. Further methods are provided for creating a patient having a carcinoembryonic-antigen-family-member-expressing tumor by immunizing the patient with the carcinoembryonic-antigen-family-member lacking the immunosuppressive region. Pharmaceutical compositions for eliciting an effective immune response to the carcinoembryonic antigen are also provided.
REFERENCES:
patent: 6852320 (2005-02-01), Blumberg
patent: 2003/0022292 (2003-01-01), Gray-Owen et al.
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4).
Dermer (Bio/Technology, 1994, 12:320).
Gura (Science, 1997, 278:1041-1042).
Jain (Sci. Am., 1994, 271:58-65).
Taheri et al JBC vol. 275 p. 26935-26943 (2000).
Amalfitano et al. (Current Gene Therapy 2002, 2: 111-133).
The Department of Health and Human Services has released a memorandum dated Jan. 14, 2003.
Mayer Lloyd
Stanners Clifford P.
Huff Sheela J
Klauber & Jackson LLC
McGill University
Mount Sinai School of Medicine
LandOfFree
Enhanced immunization and suppression of oral tolerance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhanced immunization and suppression of oral tolerance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced immunization and suppression of oral tolerance will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4050998